To view this email as a web page, click here.
September 12, 2017
 
ADVERTISEMENT
 
PHARMACISTS' REPORT
 
Oral Specialty Drug Options on the Horizon
How new medications in the pipeline could be safer and easier to administer.
Read more
 
FDA Sends Warning Letter to Mylan
EpiPen manufacturer is accused of not investigating life-threating problems.
Read more
 
Biosimilars Come to Community Pharmacy
They're here, but are you ready?
Read more
 
The Top 4 Medication Errors Your Patients Are Making
The problems your patients have—what you can do about it.
Read more
 
ADVERTISEMENT
Ad description here
 

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.